Corporate Banner
Satellite Banner
Technology Networks Header
Tuesday, July 29, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Eppendorf Launches its New Spring 2014 Advantage Offer
Saturday, April 05, 2014
New offer enables customers to purchase products at favourable prices.

Metabolon Launches Fourth Generation DiscoveryHD4™ Metabolomics Platform
Saturday, April 05, 2014
New technology advancements have potential to lead the way to new scientific breakthroughs, novel biomarkers and discoveries, and support diagnostic product pipeline.

AB SCIEX Announces Immunosuppressants Kit for Use by Doctors in Europe to Help Care for Organ Transplant Patients
Friday, April 04, 2014
The SCIEX IVD-MS™ Immunosuppressants kit is designed to give clinicians fast, accurate information about the level of immunosuppressant drug circulating in a patient’s body.

Newborn Screening Solution from AB SCIEX
Friday, April 04, 2014
Solution provides early detection indicators of metabolic disorders, helping doctors in Europe make babies’ health more predictable.

Techne’s New In Situ Hybridization Adapter
Friday, March 28, 2014
Delivers a quick, economical solution for 96-well thermal cycler owners.

BD Launches Innovative Diabetes Pen Needle
Thursday, March 27, 2014
BD Micro-Fine Ultra™ with Pentapoint 5-bevel technology helps to enhance patient comfort.

EKF Molecular Highlights Ultra-Sensitive Cancer Mutation Detection Kits
Wednesday, March 26, 2014
PointMan™ DNA-enrichment kits offer unrivalled cancer gene detection in whole blood.

New Surface and Surface Interface Diagnostic Systems
Wednesday, March 26, 2014
Hiden’s new tools based on UHV Secondary Ion Mass Spectrometry technique.

Eppendorf Launches New Mastercycler nexus X2
Friday, March 14, 2014
Provides solution for simultaneous PCR runs.

<< 2 3 4 5 6 7 8 >>
Showing Results 41 - 50 of 443
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv